素和补充因子D活性:肥胖症中的免疫相关缺陷
概括
肥胖模型中缺乏的蛋白质阿迪普辛 (adipsin) 与补充因子D一样起作用,这表明阿迪普辛和补充系统意外地参与调节能量平衡.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
背景情况:
- 脂肪细胞中的血清蛋白酶阿迪普辛在肥胖模型中缺乏.
- 缺陷的基因表达与肥胖有关.
- 阿迪普辛的功能在很大程度上仍未被阐明.
研究的目的:
- 为了净化和表征重组小鼠脂.
- 为了阐明阿迪普辛的生化和酶性质.
- 调查素在补充激活和能量平衡中的作用.
主要方法:
- 净化复合小鼠脂的净化.
- 生物化学和酶分析以确定素活性.
- 评估补充替代途径激活和红细胞溶解.
- 在各种肥胖模型中比较素活性.
主要成果:
- 激活的氨酸表现出类似于补充因子D的活性,分裂补充因子B.
- 阿迪普辛激活补充的替代途径,导致红细胞溶解.
- 在多种肥胖模型 (ob/ob,db/db,MSG注射小鼠,fa/fa大鼠) 中观察到显著降低补充因子D活性 (58-80%).
结论:
- 阿迪普辛的功能类似于补充D因子.
- 阿迪普辛激活了补充替代途径.
- 素和补充替代途径可能在调节系统能量平衡方面发挥关键作用.
更多相关视频
06:08Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
10:40Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
相关概念视频
Humoral Immune Responses
Overview
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
